Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Offer for subscription

31 Oct 2019 17:02

RNS Number : 8791R
Amati AIM VCT PLC
31 October 2019
 

Amati AIM VCT plc

31 October 2019

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Offer for subscription

The Directors of Amati AIM VCT plc are pleased to announce that the Company has today published a prospectus (the "Prospectus") in connection with proposals to raise up to £25,000,000 (with an over-allotment facility to raise up to a further £20,000,000), by way of an offer for subscription (the "Offer") of new ordinary shares (the "New Shares") and the issue of up to a further £5,000,000 of New Shares under the Dividend Re-Investment Scheme.

The Offer will open on 31 October 2019 and will close at 12 noon on 2 April 2020 in relation to the tax year 2019/2020 and at 12 noon on 16 October 2020 in relation to the tax year 2020/2021 (unless the Offer is fully subscribed before this date and/or the Board closes the Offer earlier, which it may do in its sole discretion). Applications under the Offer will be processed from 31 October 2019. Multiple applications under the Offer from the same investor in the same tax year will not be accepted. The Directors have set the maximum amount that can be raised under the Offer prior to 31 January 2020 at £15,000,000. The amount to be raised after 31 January 2020 will be £25,000,000 less the amount already raised under the Offer (subject to any exercise of the over-allotment facility). If sufficient qualifying investments have been made from the initial proceeds of the Offer, and the Directors believe that there is a pipeline of investments to utilise the funds raised, the Board may use the over-allotment facility to raise up to a further £20 million under the Offer.

The first allotment of New Shares under the Offer is expected to take place on or around 25 November 2019 and thereafter allotments will be made on a monthly basis (or at such other times as the Board, in its sole discretion, may decide).

The number of New Shares to be issued under each allotment will be determined by the relevant offer price calculated on the following basis.

For existing shareholders and those investing through an authorised financial intermediary, the offer price is calculated by dividing the last published NAV per share at the time of allotment by 0.99 to allow for issue costs of 1% (calculated in pence and rounded up to the nearest two decimal places).For all other investors (i.e. investors other than existing shareholders and those investing through an authorised financial intermediary) the offer price is calculated by dividing the last published NAV per share at the time of allotment by 0.97 to allow for issue costs of 3% (calculated in pence and rounded up to the nearest two decimal places).

The Prospectus is available at www.amatiglobal.com and www.morningstar.co.uk/uk/nsm and, until 30 October 2020, copies are available for collection, free of charge, from the offices of Amati Global Investors and the offices of Dickson Minto W.S. on any Business Day. Copies can also be requested by contacting Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

Subscriptions can be made online at www.amatioffer.com or by completing the subscription form contained in the Prospectus.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPMBBFTMBAJBFL
Date   Source Headline
2nd May 20253:29 pmRNSNet Asset Value(s)
1st May 20255:31 pmRNSChange of Manager, Change of Name and Board Change
1st May 202510:42 amRNSTotal Voting Rights
25th Apr 20255:00 pmRNSNet Asset Value(s)
23rd Apr 202512:16 pmRNSTransaction in Own Shares
23rd Apr 20259:33 amRNSNet Asset Value(s)
16th Apr 202512:32 pmRNSTransaction in Own Shares
16th Apr 20257:02 amRNSDividend Declaration
16th Apr 20257:01 amRNSAnnual Financial Report
16th Apr 20257:00 amRNSUpdate on Change of Investment Manager
9th Apr 20252:39 pmRNSTransaction in Own Shares
7th Apr 202510:39 amRNSTransaction in Own Shares
4th Apr 20254:46 pmRNSNet Asset Value(s)
4th Apr 20252:32 pmRNSTransaction in Own Shares
3rd Apr 20254:29 pmRNSTransaction in Own Shares
1st Apr 20254:34 pmRNSNet Asset Value(s)
1st Apr 202512:38 pmRNSTotal Voting Rights
31st Mar 20255:00 pmRNSTransaction in Own Shares
26th Mar 20259:57 amRNSTransaction in Own Shares
25th Mar 20258:54 amRNSTransaction in Own Shares
21st Mar 20254:05 pmRNSNet Asset Value(s)
14th Mar 20254:06 pmRNSNet Asset Value(s)
10th Mar 202511:35 amRNSCompliance with Market Abuse Regulation
7th Mar 20254:12 pmRNSNet Asset Value(s)
4th Mar 20254:40 pmRNSTransaction in Own Shares
3rd Mar 20254:18 pmRNSNet Asset Value(s)
3rd Mar 202510:27 amRNSTotal Voting Rights
28th Feb 20253:09 pmRNSTerms of Appointment of New Investment Manager
27th Feb 20254:38 pmRNSTransaction in Own Shares
24th Feb 202512:23 pmRNSNet Asset Value(s)
24th Feb 202510:06 amRNSTransaction in Own Shares
14th Feb 20253:06 pmRNSNet Asset Value(s)
11th Feb 202510:25 amRNSTransaction in Own Shares
7th Feb 20254:50 pmRNSNet Asset Value(s)
3rd Feb 20255:53 pmRNSNet Asset Value(s)
3rd Feb 20259:09 amRNSTotal Voting Rights
24th Jan 20254:36 pmRNSNet Asset Value(s)
24th Jan 20253:02 pmRNSTransaction in Own Shares
20th Jan 202510:04 amRNSNet Asset Value(s)
14th Jan 202510:06 amRNSTransaction in Own Shares
10th Jan 20255:12 pmRNSNet Asset Value(s)
6th Jan 20251:49 pmRNSTransaction in Own Shares
2nd Jan 20255:10 pmRNSNet Asset Value(s)
2nd Jan 202511:41 amRNSTransaction in Own Shares
2nd Jan 202511:15 amRNSTotal Voting Rights
20th Dec 20245:12 pmRNSNet Asset Value(s)
20th Dec 20249:54 amRNSDirector Declaration
13th Dec 20243:41 pmRNSNet Asset Value(s)
12th Dec 20243:37 pmRNSDividend Declaration
11th Dec 202410:51 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.